Filing Details
- Accession Number:
- 0001179110-20-008002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-02 17:57:46
- Reporting Period:
- 2020-06-30
- Accepted Time:
- 2020-07-02 17:57:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1646649 | Jonathan Sheena | C/O Natera, Inc., 201 Industrial Road Suite 410 San Carlos CA 94070 | Chief Technology Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-06-30 | 28,784 | $9.59 | 277,854 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-06-30 | 63,331 | $10.41 | 341,185 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-06-30 | 92,115 | $49.44 | 249,070 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-06-30 | 28,784 | $0.00 | 28,784 | $9.59 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-06-30 | 63,331 | $0.00 | 63,331 | $10.41 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 40,830 | 2026-04-07 | No | 4 | M | Direct | |
| 39,068 | 2027-06-08 | No | 4 | M | Direct |
Footnotes
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2019.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.00 to $49.97 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option shares vested fully and became exercisable on April 1, 2020.
- The option shares vest over four years. 25% of the option shares vest and become exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
